WA

Wasim Ahamad

Active Director Director DIN 06492633
DIN 06492633 First appointment Apr 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2013
Shareholding value •••• Premium profile

About Wasim Ahamad

Data last updated:

Wasim Ahamad is a Director at Curarent Pharmaceutical Private Limited (since 2013). The company operates in Pharma. Curarent Pharmaceutical Private Limited reported revenue of ₹9.9 Lakh (FY 2021).

DIN 06492633
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2013
Oldest Company Age 13 yrs
Largest company Curarent Pharmaceutical Private Limited · ₹9.9 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20132013₹9.9 Lakh (FY 2021)Active

Board colleagues of Wasim Ahamad

NameDINCompanyDesignation
Nikhat Jahan Khan06492572Curarent Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curarent Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Wasim Ahamad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wasim Ahamad

Wasim Ahamad currently holds 1 directorship: Curarent Pharmaceutical Private Limited (Director, since 02 Apr 2013, revenue ₹9.9 Lakh (FY 2021)).

Wasim Ahamad was first appointed on 02 Apr 2013 as Director at Curarent Pharmaceutical Private Limited.

The current boards of Wasim Ahamad's companies include Nikhat Jahan Khan (Curarent Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available